U-Blot® Research Grade Anti-Human CD160 (ELB021)Cat. No. WA1324Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human CD160 (ELB021)Cat. No. WA1324
U-Blot® Research Grade Anti-Human CD16/FCGR3 Antibody (GMA-161)Cat. No. WA1323
U-Blot® Research Grade Anti-Human CD157/BST1 (MEN1112)Cat. No. WA1322
U-Blot® Research Grade Anti-Human CD156b/ADAM17 Antibody (D5P2A11/D5)Cat. No. WA1321
U-Blot® Research Grade Anti-Human CD156b/ADAM17 (MEDI3622)Cat. No. WA1320
U-Blot® Research Grade Anti-Human CD156b/ADAM17 (D8P1C1)Cat. No. WA1319
U-Blot® Research Grade Anti-Human CD155/PVR Antibody (Ntx1088)Cat. No. WA1318
U-Blot® Research Grade Anti-Human CD155/PVR Antibody (Ab825)Cat. No. WA1317
U-Blot® Research Grade Anti-Human CD154/CD40LG/TNFSF5 (AT-1501)Cat. No. WA1316
U-Blot® Research Grade Anti-Human CD154/CD40LG/TNFSF5 (ABI793)Cat. No. WA1315
U-Blot® Research Grade Anti-Human CD152/CTLA4 (YH-001)Cat. No. WA1314
U-Blot® Research Grade Anti-Human CD152/CTLA4 (XTX101)Cat. No. WA1313